JPRN-UMIN000023269已完成未知
Post marketing study of sofosbuvir and ribavirin for hepatitis C virus genotype 2 infection - Post marketing study of sofosbuvir and ribavirin for hepatitis C virus genotype 2 infection
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)pregnant woman 2)decompensated cirrhosis 3)severe renal function(<eGFR30)
研究者
相似试验
已完成
不适用
Post marketing study of sofosbuvir and ledipasvir for genotype 1 hepatitis C virus infectioHepatitis virus infectionJPRN-UMIN000023271Wakayama Medical University200
招募中
不适用
Evaluation of the efficacy of sofosbuvir and ribavirin for Japanese hepatitis C patients: a prospective study in real-life settings.chronic hepatitis CJPRN-UMIN000019469Toranomon Hospital100
招募中
不适用
Efficacy and safety of sofosbuvir and ribavirin in patients with chronic hepatitis CPatients with chronic hepatitis C virus infectionJPRN-UMIN000017703Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology500
已完成
不适用
Prospective study of Sofosbuvir and Ledipasvir for HCV genotype 1 infected Japanese patientsGenotype 1 infected chronic liver diseasesJPRN-UMIN000019400Osaka City University and affiliated hospitals400
已完成
不适用
Efficacy of sofosbuvir and ribavirin therapy in patients with genotype 2 hepatitis C virus: Significance of variants associated with resistance in NS3, NS5A and NS5B regiothe patients infected with genotype 2 HCV who received combination therapy with sofosbvir and rivabirin.JPRN-UMIN000018089Department of Gastroenterology & Hepatology, Saitama Medical University40